In its September 21 edition, Fortune Business Insights points out that the global natural health medicines market is estimated at 71.92 billion USD in 2025 and is expected to have a CAGR of 7.23% to reach 137.49 billion USD by 2034.

We are determined to be a key asset for the sustained growth of the natural health industry

This strong growth is driven by consumers’ tendency to prefer more natural products for health and wellness purposes. Plant-based products are also gaining popularity among patients and healthcare professionals, mainly for their ability to provide better immunity than synthetic medicines. Since the COVID-19 pandemic and with the increasing prevalence of chronic diseases such as obesity, diabetes, and cardiovascular problems, among others, consumers are increasingly prioritizing preventive healthcare over reactive disease treatment. This largely explains the growing demand for natural products focused on fitness, immunity, and mental health. Plus, younger generations are adopting a lifestyle that’s not only healthier but also more sustainable and environmentally conscious.

“Aplantex’s proprietary and customizable green biotechnology platform, which provides a continuous and sustainable supply of plant-derived active compounds, is perfectly in line with these major trends. Especially since it offers a relevant solution to the disruptions of traditional supply chains caused by climate change and recurring geopolitical crises,” says Patrick Charest, B. Sc., P. Eng., mMBA, CEO of Aplantex.

Share : Back to blog